Trials / Completed
CompletedNCT00854659
A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study of the Safety, Tolerability and Pharmacokinetics of ABT-102 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of three different strengths of an investigational product dosed twice a day over 7 days in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-102 | BID tablets, 7 days of treatment |
| DRUG | Placebo | BID tablets, 7 days of treatment |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-06-01
- First posted
- 2009-03-03
- Last updated
- 2010-11-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00854659. Inclusion in this directory is not an endorsement.